Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

MSGS vs LLYVK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MSGS Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 4–6 Matrix Metrics)

MSGS Overall Winner 6-Pillar Tally: MSGS 3 – 3 LLYVK Matrix Metrics: MSGS 4 – 6 LLYVK

As of Nov 20, 2026, Madison Square Garden Sports Corp. (MSGS) is the stronger overall head-to-head candidate over Liberty Media Corporation Series C Liberty Live (LLYVK) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). MSGS carries a Unified Composite Score of 60.1/100 (BUY) at $384.39 (72.5x Forward P/E, 11.8% operating margin), whereas LLYVK carries 45.6/100 (HOLD) at $102.74 (49.8x Forward P/E, -9.8% operating margin).

  • Growth vs. Quality Trade-Off: MSGS earns the overall head-to-head edge with a stronger Unified Composite Score (60.1/100 BUY vs. LLYVK 45.6/100 HOLD) and 0.57β · 28% Vol risk profile, whereas LLYVK leads top-line expansion (+71.6% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MSGS vs LLYVK
MSGS NYSE Head-to-Head Winner
Madison Square Garden Sports Corp.
Services-Miscellaneous Amusement & Recreation
$384.39
-1.09% 1D
Market Cap $9.4B
TTM Revenue $1.15B
Forward P/E 72.5x
Beta / 30D Vol 0.57β · 28% Vol
Unified Composite Score
60.1 / 100 BUY
Tech 52.0 Fund 59.0 Flow 70.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.4 · SMA20: $402.13 · SMA50: $398.93
LLYVK NASDAQ
Liberty Media Corporation Series C Liberty Live Common Stock
Services-Motion Picture & Video Tape Production
$102.74
-1.96% 1D
Market Cap $9.6B
TTM Revenue $451M
Forward P/E 49.8x
Beta / 30D Vol 0.58β · 25% Vol
Unified Composite Score
45.6 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 44.9 · SMA20: $105.30 · SMA50: $101.28

6-Pillar Scorecard Institutional Category Breakdown (MSGS 3 – 3 LLYVK)

Columns: Metric · MSGS · LLYVK
1. Valuation Multiples LLYVK
Forward P/E 72.5x 49.8x
Trailing P/E N/M 49.8x
PEG Ratio N/M N/M
EV / Revenue 9.1x 21.4x
2. Growth & Scale LLYVK
Revenue Growth (YoY) +36.7% +71.6%
Earnings Growth (YoY) +644.9% +0.0%
TTM Revenue (USD) $1.15B $451M
Market Cap $9.4B $9.6B
3. Profitability & Quality MSGS
Gross Margin 33.6% 19.8%
Operating Margin 11.8% -9.8%
Net Profit Margin 0.7% -11.2%
Return on Equity (ROE) -12.3% 0.0%
4. Balance Sheet & Cash Flow MSGS
Cash Generation (TTM) -$353,000 -$18M EBITDA
Cash Flow Margin -0.0% -4.0% EBITDA Mgn
Net Cash / Leverage $1.15B Net Debt 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning MSGS
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 28.3% (23rd %ile) 33.0% (<1st %ile)
Put/Call OI Skew 0.67x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat LLYVK
OpEx & R&D Intensity 21.8% of Rev ($252M) 29.6% of Rev ($134M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Entertainment Operator Entertainment Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MSGS (4) vs LLYVK (6)
Institutional Metric MSGS LLYVK Criterion Row Edge
Market Capitalization
Scale
$9.4B $9.6B Larger Scale LLYVK
Trailing P/E Ratio
Valuation
N/M 49.8x Lower Multiple LLYVK
Forward P/E Ratio
Valuation
72.5x 49.8x Lower Multiple LLYVK
Revenue Growth (YoY)
Growth
+36.7% +71.6% Higher Growth LLYVK
Operating Margin (TTM)
Profitability
11.8% -9.8% Higher Margin MSGS
Net Profit Margin
Profitability
0.7% -11.2% Higher Margin MSGS
Return on Equity (ROE)
Capital Efficiency
-12.3% 0.0% Higher ROE LLYVK
52-Week Range Position
Momentum
76% ($208–$439) 72% ($77–$113) Stronger Trend MSGS
Beta / 30D Volatility
Risk Regime
0.57β · 28% Vol 0.58β · 25% Vol Lower Realized Risk LLYVK
Unified Institutional Score
Composite Signal
60.1 / 100 (BUY) 45.6 / 100 (HOLD) Higher Composite MSGS
Trailing 12M Revenue (USD)
Operating Scale
$1.15B $451M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
33.6% 19.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.1x EV/Rev N/M PEG · 21.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$353,000 ($1.15B Net Debt) -$18M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon LLYVK +4.79 pp
MSGS: -4.58% · LLYVK: +0.21%
3M Horizon LLYVK +0.42 pp
MSGS: -3.44% · LLYVK: -3.02%
6M Horizon MSGS +8.55 pp
MSGS: +14.7% · LLYVK: +6.15%
1Y Horizon MSGS +51.95 pp
MSGS: +78.65% · LLYVK: +26.7%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MSGS vs LLYVK. Trailing 12-month operating profitability (MSGS 11.8% vs LLYVK -9.8%) and valuation multiples (MSGS 72.5x vs LLYVK 49.8x Forward P/E) are benchmarked directly in Pillar 4 below.

MSGS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.15B
Gross Margin33.6%
Op. Margin11.8%
ROE / Fwd P/E-12.3% · 72.5x
LLYVK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$451M
Gross Margin19.8%
Op. Margin-9.8%
ROE / Fwd P/E0.0% · 49.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MSGS CONSOLIDATION
94d in phase · OBV NEUTRAL
Current IV 28.3%
IV Percentile 23rd %ile
Put/Call OI Skew 0.67x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact MSGS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LLYVK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 33.0%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LLYVK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MSGS Moat Profile Cyclical / Execution-Driven Positioning
Entertainment Operator
Competes within the Entertainment value chain with $9.4B market capitalization and 11.8% operating margin.
OpEx & R&D Reinvestment 21.8% of Rev ($252M)
90D Engineering Disclosures 0 Published
LLYVK Moat Profile Cyclical / Execution-Driven Positioning
Entertainment Operator
Competes within the Entertainment value chain with $9.6B market capitalization and -9.8% operating margin.
OpEx & R&D Reinvestment 29.6% of Rev ($134M)
90D Engineering Disclosures 0 Published

Investor FAQ MSGS vs LLYVK Key Questions & Quantitative Answers

As of Nov 20, 2026, Madison Square Garden Sports Corp. (MSGS) is the stronger overall head-to-head candidate over Liberty Media Corporation Series C Liberty Live (LLYVK) in the Tradestie Institutional Equity Comparison Engine, winning 4–6 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). MSGS carries a Unified Composite Score of 60.1/100 (BUY) at $384.39 (72.5x Forward P/E, 11.8% operating margin), whereas LLYVK carries 45.6/100 (HOLD) at $102.74 (49.8x Forward P/E, -9.8% operating margin). Growth vs. Quality Trade-Off: MSGS earns the overall head-to-head edge with a stronger Unified Composite Score (60.1/100 BUY vs. LLYVK 45.6/100 HOLD) and 0.57β · 28% Vol risk profile, whereas LLYVK leads top-line expansion (+71.6% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

LLYVK leads the Growth & Scale pillar: MSGS posts +36.7% YoY revenue growth and +644.9% YoY earnings growth on $1.15B TTM revenue (33.6% gross margin, 11.8% operating margin), compared with LLYVK at +71.6% YoY revenue growth and +0.0% YoY earnings growth on $451M TTM revenue (19.8% gross margin, -9.8% operating margin). On trailing 12-month operating scale, MSGS generates $1.15B in USD-normalized revenue versus $451M for LLYVK. In operating R&D and SG&A reinvestment, MSGS deploys 21.8% of Rev ($252M) (0 90-day corporate R&D disclosures) versus 29.6% of Rev ($134M) (0 disclosures) for LLYVK.

LLYVK screens cheaper on headline valuation multiples. MSGS trades at 72.5x Forward P/E, N/M Trailing P/E, N/M PEG, and 9.1x EV/Revenue (-0.0% FCF margin), whereas LLYVK trades at 49.8x Forward P/E, 49.8x Trailing P/E, N/M PEG, and 21.4x EV/Revenue (-4.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MSGS (-12.3% ROE) versus LLYVK (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, MSGS carries 28.3% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.67x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.57β · 28% Vol realized risk). By comparison, LLYVK carries 33.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.58β · 25% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.